Covid 19 Research using Clinical Trials (Home Page)
SimvastatinWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (3)
Correlated MeSH Terms (3)
|
Name (Synonyms) |
Correlation |
D055371 | Acute Lung Injury NIH | 0.12 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.12 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.10 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
The CRASH-19 trial is a multinational, open-label, factorial, randomised trial in adults
hospitalised with suspected or confirmed acute COVID-19 infection.
NCT04343001 Covid-19 Drug: Aspirin Drug: Losartan Drug: Simvastatin
Primary Outcomes
Description: Cause of death will be described
Measure: Death
Time: up to 28 days of randomisation
Secondary Outcomes
Measure: Myocardial infarction Time: up to 28 days of randomisation
Measure: Congestive cardiac failure Time: up to 28 days of randomisation
Measure: Severe cardiac arrythmia Time: up to 28 days of randomisation
Measure: Myocarditis Time: up to 28 days of randomisation
Measure: Respiratory failure including ARDS Time: up to 28 days of randomisation
Measure: Viral pneumonitis Time: up to 28 days of randomisation
Measure: Acute renal failure Time: up to 28 days of randomisation
Measure: Sepsis Time: up to 28 days of randomisation
Measure: Stroke Time: up to 28 days of randomisation
Measure: Gastrointestinal bleeding Time: up to 28 days of randomisation
Measure: Receipt of non invasive or mechanical ventilation Time: up to 28 days of randomisation
Measure: Ability to self care at hospital discharge Time: up to 28 days of randomisation
No related HPO nodes (Using clinical trials)